Navigation Links
ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
Date:4/8/2008

Long-term arrangement between two leading non-profit research institutes designed to validate drug targets for the fatal neurodegenerative disease that affects 30,000 Americans

CAMBRIDGE, Mass., April 8, 2008 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) today announced it has entered into an agreement with the Allen Institute for Brain Science in Seattle, Wash. for in situ hybridization (ISH) services using diseased tissues from a preclinical animal model of amyotrophic lateral sclerosis -- ALS, or Lou Gehrig's disease. ALS is a progressive and fatal neurodegenerative disease with no known cause or cure. Under the terms of the agreement, the Allen Institute will perform ISH for genes, in the spinal cord, identified by ALS TDI researchers as being associated with the disease's progression. The aim of this work is to identify cells that are associated with changes in gene expression so that treatments can be directed towards those cells specifically.

"The ongoing data mining efforts at the ALS TDI are identifying hundreds of therapeutic targets that need to be evaluated in vivo. Identification of cells to be targeted by treatments is a crucial step in therapeutic development," said Steven Perrin, Ph.D., Chief Scientific Officer of ALS TDI. "The publication of the Allen Brain Atlas--Mouse Brain project established the Allen Institute as leaders in ISH technologies and capabilities."

At the end of 2007, ALS TDI completed an enormous database of transcriptome information for the SOD1 mouse model, the leading mouse model used internationally by ALS researchers. ALS TDI, a leader in translational research for ALS, has also initiated a similar project and experiment collecting blood samples from people living with the disease today and is expected to expand their collection project and experiments to include other tissues. Through a multi-year funding partnership with the Muscular Dystrophy Association and its
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
6. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
7. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
8. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
9. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Creekridge Capital, an independent vendor-focused ... vendors so far in 2014 to their portfolio ... are from both the healthcare and technology industries. ... well-known multi-national companies. Each of these new vendors ... products including: standard leasing products, subscription solutions, a ...
(Date:7/23/2014)... YORK , July 23, 2014 ... Beach, Fla. , is an emerging player ... diagnostic systems for bio-threat detection and rapid medical ... called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was ... Homeland Security ("DHS") Science & Technology directorate, and ...
(Date:7/23/2014)... MEETING, Pa. , July 23, 2014 ... INO) today announced successful results from its ... VGX-3100 in women with biopsy-proven cervical intraepithelial ... (HPV) types 16 or 18. Treatment with ... regression of CIN2/3 to CIN1 or no ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5
(Date:7/23/2014)... News) -- Painful or itchy skin lesions could be ... "Patients sometimes have multiple lesions that are suspicious looking, ... high concerns for non-melanoma skin cancers," study author Dr. ... of Medicine, said in a Temple University Health System ... of 268 patients who were confirmed to have skin ...
(Date:7/23/2014)... Agricultural and Forestry University in Shaanxi province, and the ... agreement that lays the groundwork for establishing the Sino-U.S. ... The signing ceremony was held in the city of ... the U.S. Department of Agriculture and China,s Ministry of ... event for UC Davis and for our World Food ...
(Date:7/23/2014)... 2014 The American Telemedicine Association ... twentieth annual meeting and tradeshow focused exclusively on ... attract over 5,000 attendees and more than 250 ... 3-5, 2015, in Los Angeles. , ATA’s annual ... professionals from researchers, clinicians, hospital and university administrators, ...
(Date:7/23/2014)... 23, 2014 Bodybuilding.com, the Internet’s most-visited ... of nutritional supplements, has officially opened the polls for ... , the fastest growing sports nutrition company, is up ... of the Year, Best Tasting Protein of the Year- ... of the year - Whey-HD™, Pre-workout Supplement of the ...
(Date:7/23/2014)... The voice on the recording was low and calm as the ... infected with the human immunodeficiency virus (HIV) that causes AIDS: “My ... know I was on the floor flat on my face boohooing, ... the recording ended less than 10 minutes later. “Don’t feel like ... it is just God setting you up for something greater,” the ...
Breaking Medicine News(10 mins):Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3
... , Transplant surgeons at Johns Hopkins who have reviewed the ... that it is not simply racial differences, but rather flaws ... and education levels, in addition to biological factors, that are ... in African Americans. In a report on the review ...
... ... compensation costs , ... Oak Brook, IL (Vocus) May 31, 2010 -- AthletiCo Physical and Occupational Therapy ... OTR/L, to manage its Ergonomics and Job Analysis Program. Harris’s role as the ...
... urological problems, studies show , MONDAY, May 31 (HealthDay ... start exercising and steer clear of smoking, new research ... urinary health in women and sexual health in men. ... Finnish women, aged 18 to 79, about smoking and ...
... Medical Association Journal ) found a 68% increase in the ... link only) http://www.cmaj.ca/embargo/cmaj091208.pdf . Antidepressants are widely ... use them at some point during the first trimester. Discontinuing ... mother and baby at risk. Most previous studies ...
... illnesses kill more females than males, organizers say ... cancer death rates for women are generally on ... fatalities are rising, the American Lung Association (ALA) ... every year from tobacco-related illness, the ALA estimates. ...
... ... ... Those seeking to obtain ultimate health should take a page from author Fay Julius-Williams’ book, ... previous years and now walking in health, the author penned the new title in order ...
Cached Medicine News:Health News:Lack of private insurance contribute to higher deaths among black heart transplant patients 2Health News:Lack of private insurance contribute to higher deaths among black heart transplant patients 3Health News:Lack of private insurance contribute to higher deaths among black heart transplant patients 4Health News:AthletiCo Physical Therapy Enhances Work Rehabilitation Program by Offering Ergonomics and Job Analysis 2Health News:AthletiCo Physical Therapy Enhances Work Rehabilitation Program by Offering Ergonomics and Job Analysis 3Health News:Antidepressants in pregnancy increase risk of miscarriage 2Health News:Women Smokers Targeted on 'World No Tobacco Day' 2Health News:Obtain Ultimate Health from Tips in New Xulon Press Title 2
Small curved rounded blade. Flat serrated handle with polished finish....
For use with E0828 needle and gouge set and E0828 C handle. Triangular shape curved 5.0 mm blade. Polished finish. Most popular size or model....
Set consists of one each:E0824 A replacement burr set. E0824 B handle....
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle....
Medicine Products: